Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15176915rdf:typepubmed:Citationlld:pubmed
pubmed-article:15176915lifeskim:mentionsumls-concept:C0027361lld:lifeskim
pubmed-article:15176915lifeskim:mentionsumls-concept:C0025362lld:lifeskim
pubmed-article:15176915lifeskim:mentionsumls-concept:C0033978lld:lifeskim
pubmed-article:15176915lifeskim:mentionsumls-concept:C0240320lld:lifeskim
pubmed-article:15176915lifeskim:mentionsumls-concept:C0086569lld:lifeskim
pubmed-article:15176915pubmed:issue4lld:pubmed
pubmed-article:15176915pubmed:dateCreated2004-6-4lld:pubmed
pubmed-article:15176915pubmed:abstractTextThe use of psychotropic medication with persons who have mental retardation was surveyed. Data were collected on a large sample of Oklahomans in both 1994 and 2000. Analysis revealed that the use of antidepressant medication increased dramatically over the course of the study, apparently as a function of increased use of SSRI medications. Antipsychotic medication did not change dramatically, but a shift to the newer atypical antipsychotic medications was noted. In a separate analysis of persons who moved from an institutional setting to a community-based setting, evidence suggested an increased use of psychotropic medication.lld:pubmed
pubmed-article:15176915pubmed:languageenglld:pubmed
pubmed-article:15176915pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15176915pubmed:citationSubsetIMlld:pubmed
pubmed-article:15176915pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15176915pubmed:statusMEDLINElld:pubmed
pubmed-article:15176915pubmed:monthJullld:pubmed
pubmed-article:15176915pubmed:issn0895-8017lld:pubmed
pubmed-article:15176915pubmed:authorpubmed-author:SpreatScottSlld:pubmed
pubmed-article:15176915pubmed:authorpubmed-author:ConroyJames...lld:pubmed
pubmed-article:15176915pubmed:authorpubmed-author:FullertonAman...lld:pubmed
pubmed-article:15176915pubmed:issnTypePrintlld:pubmed
pubmed-article:15176915pubmed:volume109lld:pubmed
pubmed-article:15176915pubmed:ownerNLMlld:pubmed
pubmed-article:15176915pubmed:authorsCompleteYlld:pubmed
pubmed-article:15176915pubmed:pagination322-31lld:pubmed
pubmed-article:15176915pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15176915pubmed:meshHeadingpubmed-meshheading:15176915...lld:pubmed
pubmed-article:15176915pubmed:meshHeadingpubmed-meshheading:15176915...lld:pubmed
pubmed-article:15176915pubmed:meshHeadingpubmed-meshheading:15176915...lld:pubmed
pubmed-article:15176915pubmed:meshHeadingpubmed-meshheading:15176915...lld:pubmed
pubmed-article:15176915pubmed:meshHeadingpubmed-meshheading:15176915...lld:pubmed
pubmed-article:15176915pubmed:meshHeadingpubmed-meshheading:15176915...lld:pubmed
pubmed-article:15176915pubmed:meshHeadingpubmed-meshheading:15176915...lld:pubmed
pubmed-article:15176915pubmed:meshHeadingpubmed-meshheading:15176915...lld:pubmed
pubmed-article:15176915pubmed:meshHeadingpubmed-meshheading:15176915...lld:pubmed
pubmed-article:15176915pubmed:meshHeadingpubmed-meshheading:15176915...lld:pubmed
pubmed-article:15176915pubmed:year2004lld:pubmed
pubmed-article:15176915pubmed:articleTitleStatewide longitudinal survey of psychotropic medication use for persons with mental retardation: 1994 to 2000.lld:pubmed
pubmed-article:15176915pubmed:affiliationWoods Services, Langhorne, Pennsylvania 19047, USA. sspreat@woods.orglld:pubmed
pubmed-article:15176915pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15176915pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed